BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3010525)

  • 1. [LAV/HTLV III antibody in patients with acute hepatitis B 1975-1984].
    Arendrup M; Lindhardt BO; Krogsgaard K; Gaub J; Nielsen JO
    Ugeskr Laeger; 1986 Mar; 148(14):825-8. PubMed ID: 3010525
    [No Abstract]   [Full Text] [Related]  

  • 2. [Increase in the prevalence of antibodies against LAV/HTLV III in drug addicts in West Germany].
    Zoulek G; Gürtler L; Eberle J; Lorbeer B; Deinhardt F
    Dtsch Med Wochenschr; 1986 Apr; 111(15):567-70. PubMed ID: 3007065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Syphilis profile among LAV/HTLV III antibody-positive and negative homosexual men].
    Weismann K; Sindrup JH; Wantzin GL
    Ugeskr Laeger; 1986 Mar; 148(14):823-5. PubMed ID: 3010524
    [No Abstract]   [Full Text] [Related]  

  • 4. [The occurrence of LAV/HTLV III antibodies in patients with hemophilia in the County of Funen].
    Larsen FS; Høst A; Munk-Andersen G
    Ugeskr Laeger; 1986 Mar; 148(14):865-7. PubMed ID: 3010526
    [No Abstract]   [Full Text] [Related]  

  • 5. [Occurrence of antibody to human T-cell leukemia/lymphovirus type III (LAV/HTLV III) in venereology clientele in Copenhagen].
    Petersen CS; Wantzin GL; Gerstoft J; Lindhardt BO; Worm AM; Weismann K; Kristensen JK; Kroon S; Rasmussen LP; Avnstorp C
    Ugeskr Laeger; 1986 Mar; 148(14):821-2. PubMed ID: 3010523
    [No Abstract]   [Full Text] [Related]  

  • 6. Seroepidemiologic screening for antibodies to LAV/HTLV-III in Sri Lanka, 1980-1982.
    Miller RA; Collier AC; Buchanan TM; Handsfield HH
    N Engl J Med; 1985 Nov; 313(21):1352-3. PubMed ID: 2997608
    [No Abstract]   [Full Text] [Related]  

  • 7. [Case reports of 77 HTLV III/LAV-positive patients observed during one-year period. Preliminary note].
    Soranzo ML; Salassa B; Daziano E; Paggi GC
    Minerva Med; 1986 May; 77(20):897-900. PubMed ID: 3014379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunofluorescence in the serological study of HTLV-III/LAV].
    Picchio G; Muchinik G
    Medicina (B Aires); 1986; 46(2):247-8. PubMed ID: 3033429
    [No Abstract]   [Full Text] [Related]  

  • 9. Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell lymphotropic virus, type III/lymphadenopathy-associated virus.
    Yarchoan R; Redfield RR; Broder S
    J Clin Invest; 1986 Aug; 78(2):439-47. PubMed ID: 3016028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of HTLV-III/LAV antibodies in ex-residents from Angola and Mozambique returning to Portugal before 1979.
    Victorino RM; Maria VA; Jeffries DJ; Pinching A
    Acta Med Port; 1986; 7(1):49-50. PubMed ID: 3014826
    [No Abstract]   [Full Text] [Related]  

  • 11. [HTLV-III serology, epidemiology and clinical aspects of imprisoned i.v. drug-dependent males in Austria].
    Pont J; Neuwald C; Kunz C; Werdenich W
    Wien Klin Wochenschr; 1986 Jul; 98(14):454-7. PubMed ID: 3019019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anti-HTLV-III/LAV antibodies in hematology reactives].
    Aznar JA; Monzó E; Mayans J; Granda D; Hurtado F; Curats R
    Sangre (Barc); 1986; 31(2):215-7. PubMed ID: 3014670
    [No Abstract]   [Full Text] [Related]  

  • 13. [HTLV-III/LAV antibodies in gamma globulin preparations for intravenous use].
    Kaeser A
    Dtsch Med Wochenschr; 1986 Aug; 111(33):1263. PubMed ID: 2427300
    [No Abstract]   [Full Text] [Related]  

  • 14. [HTLV-III in patients in a hemodialysis program].
    Cuxart M; Salas M; Aubia J; Lloveras J
    Med Clin (Barc); 1986 Apr; 86(14):611. PubMed ID: 3014239
    [No Abstract]   [Full Text] [Related]  

  • 15. [Anti-LAV/HTLV-III antibodies in gamma globulin preparations destined for intravenous administration].
    Dickgiesser N; Brenner KP; Mertens T
    Dtsch Med Wochenschr; 1986 Jun; 111(26):1041. PubMed ID: 3013564
    [No Abstract]   [Full Text] [Related]  

  • 16. [Systematic detection of anti-LAV/HTLV-III antibodies in blood donors and hemophiliacs].
    Muncunill J; Forteza A; Forner N; Forteza-Rei J
    Med Clin (Barc); 1986 Apr; 86(13):565. PubMed ID: 3012224
    [No Abstract]   [Full Text] [Related]  

  • 17. [In vitro diagnosis and anti-LAV/HTLV III].
    Meyer-Lüerssen D
    J Clin Chem Clin Biochem; 1985 Dec; 23(12):889-90. PubMed ID: 3007653
    [No Abstract]   [Full Text] [Related]  

  • 18. Testing for HTLV-III/LAV antibody.
    Holston JL
    Ala J Med Sci; 1986 Jul; 23(3):269-71. PubMed ID: 3019171
    [No Abstract]   [Full Text] [Related]  

  • 19. Adult T-cell leukemia/lymphoma in Jamaica and its relationship to human T-cell leukemia/lymphoma virus type I-associated lymphoproliferative disease.
    Gibbs WN; Lofters WS; Campbell M; Hanchard B; LaGrenade L; Clark J; Cranston B; Saxinger C; Gallo R; Blattner WA
    Princess Takamatsu Symp; 1984; 15():77-90. PubMed ID: 6100652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AIDS virus antibody in polytransfused dialysis patients vaccinated against hepatitis B.
    Desmyter J; Reynders M; Goubau P
    Br Med J (Clin Res Ed); 1986 Aug; 293(6546):537. PubMed ID: 3019458
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.